Related Experiment Video
Updated: May 18, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
A role for transcription factor STAT3 signaling in oncogene smoothened-driven carcinogenesis
Dongsheng Gu1, Qipeng Fan, Xiaoli Zhang
1Wells Center for Pediatric Research, Departments of Pediatrics, Biochemistry/Molecular Biology and Pharmacology/ Toxicology, The Simon Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana 46074, USA.
Abstract:
Activation of the Hedgehog (Hh) pathway is known to drive development of basal cell carcinoma and medulloblastomas and to associate with many other types of cancer, but the exact molecular mechanisms underlying the carcinogenesis process remain elusive. We discovered that skin tumors derived from epidermal expression of oncogenic Smo, SmoM2, have elevated levels of IL-11, IL-11Rα, and STAT3 phosphorylation at Tyr(705). The relevance of our data to human conditions was reflected by the fact that all human basal cell carcinomas examined have detectable STAT3 phosphorylation, mostly in keratinocytes. The functional relevance of STAT3 in Smo-mediated carcinogenesis was revealed by epidermal specific knockout of STAT3. We showed that removal of STAT3 from mouse epidermis dramatically reduced SmoM2-mediated cell proliferation, leading to a significant decrease in epidermal thickness and tumor development. We also observed a significant reduction of epidermal stem/progenitor cell population and cyclin D1 expression in mice with epidermis-specific knockout of STAT3. Our evidence indicates that STAT3 signaling activation may be mediated by the IL-11/IL-11Rα signaling axis. We showed that tumor development was reduced after induced expression of SmoM2 in IL-11Rα null mice. Similarly, neutralizing antibodies for IL-11 reduced the tumor size. In two Hh-responsive cell lines, ES14 and C3H10T1/2, we found that addition of Smo agonist purmorphamine is sufficient to induce STAT3 phosphorylation at Tyr(705), but this effect was abolished after IL-11Rα down-regulation by shRNAs. Taken together, our results support an important role of the IL-11Rα/STAT3 signaling axis for Hh signaling-mediated signaling and carcinogenesis.
Insights
The Hedgehog (Hh) pathway activates STAT3 signaling via IL-11/IL-11Rα, driving skin cancer development. Blocking this axis reduces tumor growth, offering potential therapeutic targets for basal cell carcinoma.
Area of Science:
- Oncology
- Molecular Biology
- Dermatology
Background:
- The Hedgehog (Hh) pathway is crucial for development and implicated in various cancers, including basal cell carcinoma (BCC).
- Molecular mechanisms linking Hh pathway activation to carcinogenesis are not fully understood.
- STAT3 phosphorylation is observed in human BCCs.
Purpose of the Study:
- To elucidate the molecular mechanisms of Hh pathway-mediated skin carcinogenesis.
- To investigate the role of IL-11, IL-11Rα, and STAT3 in Hh-driven skin tumors.
- To assess the therapeutic potential of targeting the IL-11Rα/STAT3 axis.
Main Methods:
- Generated transgenic mice with oncogenic Smo (SmoM2) expression in the epidermis.
- Utilized epidermis-specific STAT3 knockout mice.
- Employed IL-11Rα null mice and neutralizing antibodies for IL-11.
- Analyzed STAT3 phosphorylation, cell proliferation, stem/progenitor populations, and cyclin D1 expression.
- Used Hh-responsive cell lines (ES14, C3H10T1/2) treated with Smo agonist purmorphamine and IL-11Rα knockdown.
Main Results:
- Epidermal SmoM2 expression elevated IL-11, IL-11Rα, and STAT3 phosphorylation (Tyr705).
- STAT3 phosphorylation was detected in human BCCs, primarily in keratinocytes.
- Epidermal-specific STAT3 knockout significantly reduced SmoM2-induced proliferation, epidermal thickness, and tumor development.
- STAT3 knockout also decreased epidermal stem/progenitor cells and cyclin D1 expression.
- Tumor development was reduced in IL-11Rα null mice and with IL-11 neutralization.
- Smo agonist induced STAT3 phosphorylation, abolished by IL-11Rα knockdown.
Conclusions:
- The IL-11Rα/STAT3 signaling axis is critical for Hh pathway-mediated skin carcinogenesis.
- STAT3 activation, potentially downstream of IL-11/IL-11Rα, drives proliferation and tumor development.
- Targeting the IL-11Rα/STAT3 axis represents a promising therapeutic strategy for Hh-driven skin cancers.
Related Concept Videos
TGF - β Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic cells are...
Hedgehog Signaling Pathway

